RCL vs RNXT · P/E 26, rev $9.28B vs rev $1.5M
Royal Caribbean Cruises Ltd (RCL) versus RenovoRx Inc (RNXT) — a side-by-side from cached financials, not a winner call.
Royal Caribbean Cruises Ltd (RCL) is a travel services company listed on US.
RenovoRx Inc (RNXT) is a biotechnology company listed on US.
Latest reported RCL revenue for 2026-06-30 was $9.28B. Net income was $2.07B. RCL currently screens at market cap $85.57B and trailing P/E 25.7.
Latest reported RNXT revenue for 2026-06-30 was $1.5M. Net income was -$6.4M. RNXT currently screens at market cap $47.0M.
RCL currently screens at market cap $85.57B and trailing P/E 25.7. RNXT currently screens at market cap $47.0M.
Not investment advice. Open the RCL and RNXT stock pages for the full models.
Not investment advice.